Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2020 16:01 ET | Source: Inozyme Pharma Inc.

Inozyme Pharma Announces Closing of Initial Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (“Inozyme”) (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of...
July 23, 2020 21:30 ET | Source: Inozyme Pharma Inc.

Inozyme Pharma Announces Pricing of Initial Public Offering

BOSTON, July 23, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (“Inozyme”) (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of...
July 17, 2020 18:05 ET | Source: Inozyme Pharma Inc.

Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals

Acquisition expands Inozyme’s intellectual property portfolio for the development of novel therapies for ENPP1 deficiency Alexion acquires ownership stake in Inozyme BOSTON, July 17, 2020 (GLOBE...